What Bruce Cleveland Knows About Category Design That Captures 76% of Medtech Market Profits

June 16, 2026

Table of contents

What Bruce Cleveland Knows About Category Design That Captures 76% of Medtech Market Value

Key Takeaways

Category design captures 76% of the total market value (market cap) created in any new category in any new market, and the leader compounds disproportionately while followers fight for the remaining 24%
Category design is structural work, not branding work; branding is expression, category is the rules of the game
You cannot create a category of one. The category leader has to recruit competitors into the category to validate it for buyers
Medtech failures show up as solutions without markets, not as bad products; the underlying issue is missing category design discipline
The category design work has to happen before brand work, product positioning, or commercial team build, not after

You have a brand identity. You have a tagline that the board signed off on. The website has been refreshed twice in the last two years. The deck has the new colour palette and the updated messaging architecture. And the sales team has a positioning statement everyone agrees on.

But the buyers in clinical meetings still ask the same first question. Which existing thing are you like? The category your founders have been trying to articulate in the brand work doesn't exist in the buyer's mental model.

So the buyer puts you in an adjacent category where an incumbent has already won. And the deal moves through a pipeline that doesn't reward your differentiation.

This post lays out what category design really means, why brand work isn't a substitute, and what the 76% market-value dynamic means for any medtech founder still trying to define their position in an existing category instead of designing a new one.

Category Is Structure. Branding Is Expression.

The first thing most medtech founders get wrong about category design is treating it as a branding exercise. Branding is the visual identity, the voice, the messaging architecture. Category design is the underlying structure that determines whether any of those branding elements can do their job.

I covered the distinction on a recent solo episode about market engineering for medtech startups raising capital:

"Category does not equal branding because branding is more of an expression. The category is more about structure. It's about setting up the context and the rules of the game."

So branding without category design is decoration on top of a structure that isn't there. The visual identity may be beautiful. The tagline may be sharp.

But if the underlying category isn't defined, the buyer evaluating the brand doesn't have anywhere to put it in their mental model. They default to the closest existing category, evaluate the brand against the incumbent's criteria, and the differentiation collapses.

Category design has to come first. Branding comes second. Founders who run brand refreshes before doing category design work pay for the refresh twice (once for the refresh itself, and again when the next refresh has to be done after the category work is complete).

The 76% Market Value Dynamic

The reason category design matters financially is that the category leader captures a disproportionate share of the market value in any new market. The numbers are not close.

On the $100B exit fix episode about mini strategics, I cited the data point directly:

"The data shows that 76% of the market capitalization of the category accrue to the category leader. If you're coming up with a category, it's like coming up with a new sport, you want to pack the stadium."

So 76% of the market value goes to the leader. The remaining 24% gets split across every follower in the category. Medtech founders who position their company as "the better alternative" to an incumbent in an existing category are mathematically opting into the 24% bucket.

The 76% bucket only opens up if the company is willing to do the work of designing a new category and positioning themselves as the leader inside it.

That math changes the calculation on category design investment. Spending six months and meaningful budget on category design work is not a marketing line item. It's the highest-leverage commercial decision the founder will make. The companies that skip the work end up competing for the 24% pool no matter how good the product is.

You Cannot Create a Category of One

The most counterintuitive piece of category design is that the founder can't define the category alone. The category leader has to recruit other companies into the category for the category to be real.

I interviewed Bruce Cleveland of Traction Gap Partners on an episode about the truth about product-market fit and category design. Bruce was specific about this dynamic:

"You can't create a category of one. If you create the category, you then have to compel others to participate in the category with you. No one's going to come to the stadium to watch the game unless they know at least two teams are playing."

That insight reframes how the leader should think about competitors. In an existing category, competitors are zero-sum threats. In a new category the leader has designed, the first few competitors are validators.

They make the category real to buyers, analysts, and investors. The leader's job is to define the category in a way that competitors will adopt the same vocabulary because the alternative is to be uncategorisable.

The medtech founders who think the goal of category design is to "own the space alone" are misreading the playbook. The goal is to define the space and then recruit followers who use the same definition. The leader's position is protected by the fact that they wrote the rules everyone else now plays by.

Why the Medtech Failure Mode Is Almost Always a Solution Without a Market

The most common medtech failure mode is what happens when a strong technical product launches into a category that hasn't been defined yet. The company has a working device, FDA clearance, and clinical data. But the buyer can't process the offering because there's no category for it.

I covered this on the same market engineering episode:

"The category really defines how your product is evaluated, okay? It's essentially setting the rules to the game. The most common thing I see in MedTech is a solution without a market."

A solution without a market is a category-design failure dressed as a product or sales failure. The founder reads it as a fundraising problem ("investors don't get it"), a sales problem ("reps can't close"), or a clinical problem ("we need more data").

The actual root cause is that the buyers don't have a category to put the product in. So no amount of sales motion, clinical evidence, or fundraising narrative compensates for the missing structural work.

I made this case more directly when I sat down with Nick Damiano of Andromeda Surgical on an episode about autonomous surgery and the future of robotics:

"Most medtech companies fail because the market never really forms around them. Clinical validation is not adoption. FDA clearance is not demand. Innovation alone does not create a category."

So clinical validation, FDA clearance, and product innovation are necessary. They're not sufficient. The category design work is what turns those three inputs into a market that buyers can engage with.

How to Run Category Design Pre-Launch

The right sequence for category design at the pre-launch stage is structural and runs over 90 to 180 days. The work is intensive but the deliverables are concrete.

First, name the problem in the buyer's vocabulary. Not the technical problem the device solves. The lived problem the buyer experiences. Surgeons don't search for "improved sacral nerve stimulation devices." They search for the patient outcome the device produces. The category language has to start from the buyer's experience, not the engineer's specifications.

Second, name the category and write a one-paragraph charter that explains the rules of the game. Who's in the category. What evaluation criteria apply. What outcomes the category is responsible for.

The charter is what the team uses to evaluate every messaging, content, and sales decision over the next two years. If a decision doesn't reinforce the charter, it doesn't ship.

Third, decide who else is in the category. The leader gets to choose which competitors to invite into the category narrative. Strong leaders pick competitors whose entry validates the category without threatening the leader's position. Weak leaders pretend they have no competitors, which kills the category before it forms.

Fourth, build the content and KOL motion that repeats the category vocabulary often enough for the market to learn it. This is the 12 to 18 month investment Bruce Cleveland talks about. It's where most companies underinvest because the return doesn't show up in quarterly pipeline reports.

For more on the upstream work that has to happen alongside category design, see the medtech commercialisation strategy framework. And for the broader sequence of how category design feeds into go-to-market motion, see the medtech go-to-market strategy playbook.

What This Means for Medtech Founders

In my experience working with medtech founders, the category design conversation usually starts after the company has already spent two years competing inside an existing category and losing on incumbent terms.

The recovery work involves naming the category the founder should have defined at launch, building the language and content motion to seed it, and recruiting the first follower companies to validate it.

So the better sequence is to do the category design work before launch. The investment is meaningful (90 to 180 days of leadership attention, $200K to $500K in committed strategy and content budget over the first 18 months).

The return is the 76% of market value that goes to the category leader at scale, plus the strategic optionality of being the company that defined the rules of the game.

Frequently Asked Questions

What is category design?

Category design is the discipline of defining a new market category, naming the rules by which products inside the category are evaluated, and positioning a company as the leader of that category.

The work spans problem framing, category naming, competitor recruitment, narrative development, and the multi-year content and KOL motion required to seed the vocabulary across the market. Category design is structural work that sits upstream of branding, messaging, and go-to-market execution.

How is category design different from branding?

Branding is the expression layer: visual identity, voice, tagline, design system, and messaging architecture. Category design is the structural layer underneath: the definition of what game is being played, who the players are, what evaluation criteria apply, and what outcomes the category is responsible for.

Branding without category design produces visual polish on top of a structural void. Category design without branding produces a real category that the leader has not yet expressed in visual form.

Why does the category leader capture 76% of market value in a new market?

The 76% market-value dynamic comes from how buyers, analysts, and investors evaluate companies inside an emerging category. The category leader gets to define the rules of evaluation, anchor the vocabulary buyers use, and shape the narrative that analysts repeat.

The compounding effect on share of mind, share of voice, and share of capital allocation produces a disproportionate share of market value over a decade. Followers in the category split the remaining 24% across multiple companies.

When should a medtech founder start category design work?

Category design work should start before product launch. Ideally 12 to 18 months before the first commercial sale. The deliverables (problem framing, category charter, competitor recruitment strategy, content and KOL motion) need that lead time to seed vocabulary across the buyer audience.

Founders who defer category design until after launch typically spend two years competing inside an existing category and then have to fund the category design work as a rescue effort, which is meaningfully more expensive than doing it pre-launch.

Listen to the Full Conversations

The episodes referenced in this post are available on The State of MedTech. Subscribe wherever you listen to podcasts.

About the Author

Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry. He works with medtech founders and commercial leaders on market engineering, commercialisation strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.